EROSIVE ESOPHAGITIS
Clinical trials for EROSIVE ESOPHAGITIS explained in plain language.
Never miss a new study
Get alerted when new EROSIVE ESOPHAGITIS trials appear
Sign up with your email to follow new studies for EROSIVE ESOPHAGITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill aims to heal esophagus damage and keep it healed
Disease control CompletedThis study tested a new medication called BLI5100 in 1250 adults with erosive esophagitis, a condition where stomach acid damages the esophagus. The goal was to see if BLI5100 works better than a standard acid-reducing drug (PPI) at healing the damage within 8 weeks and keeping i…
Matched conditions: EROSIVE ESOPHAGITIS
Phase: PHASE3 • Sponsor: Braintree Laboratories • Aim: Disease control
Last updated May 17, 2026 09:09 UTC
-
New GERD drug shows safety over one year in 400 patients
Disease control CompletedThis study tested the long-term safety of a daily medication called BLI5100 in 400 adults with gastroesophageal reflux disease (GERD). Participants took the drug once a day for up to 52 weeks. The main goal was to track any side effects. This is not a cure; patients need ongoing …
Matched conditions: EROSIVE ESOPHAGITIS
Phase: PHASE3 • Sponsor: Braintree Laboratories • Aim: Disease control
Last updated May 15, 2026 11:55 UTC